Abstract:After hematopoietic cell transplantation (HCT), the risk of acute graft-vs.-host disease (GVHD) is increased in male recipients of female grafts. Disparities for the male-associated H-Y and other minor histocompatibility antigens (mHAs) have the capacity to sensitize alloreactive donor T cells and cause GVHD in HLA-matched recipients. We asked whether regulatory T cells (Treg) exist specific for human mHA. Tregs from normal donors were isolated by CD25 immunoabsorption and cultured with dendritic cells (DC) from HLA-matched siblings in the presence of IL-2, IL-15 and rapamycin. We detected a 15-fold increase in 3H-TdR uptake at 6 days in Treg cultures stimulated by HLA-identical, mHA incompatible sibling DC compared to self-DC. The median precursor frequency of mHA-specific Treg is 1.3 (range, 0.1-13.5) cells per million total blood CD4 T cells, while the median frequency of mHA-specific conventional CD4 (Tconv) is 25 (range, 3-141) per million total blood CD4 T cells. Among 13 HLA-identical sibling pair tested in any gender combination, there was a 26 (range, 8 to 39)-fold excess mHA-specific Tconv over mHA-specific Treg in the donor blood. It is the predominance of alloreactive Tconv over Tregs that drives the immune response causing GVHD. Purified Tregs were expanded in culture with for 12 days with DC from a HLA-identical sibling, IL-2, IL-15 and rapamycin (n=5), and the frequency of mHA-specific Tregs expanded 147 to 394-folds. Tregs responded to re-stimulation with DC from the original HLA-identical sibling, but not self-DC. The mHA-specific Tregs exhibited antigen specific suppression. When Tregs were cultured at limiting dilution, we obtained 4 mHA-specific Treg clones that retained TGFb secretion in response to the sibling's mHA-disparate DC but not self-DC. One of these clones from a female donor responded to HY-antigen DBY expressed on self-APC after gene transduction and not UTY or DC alone, while another clone responded to UTY not DBY or self-DC alone. We adapted our protocol to GMP-compatible, large scale expansion of Treg from apheresis of 3.7 x 1010cells. Cultured Tregs maintained high levels of Foxp3 expression and demethylation of the Treg-specific Foxp3 gene promoter of the end-culture. mHA-specific Tregs were enriched 324-folds during the 12-day culture, indicating that we will be able to produce enough cells to exceed the numbers of mHA-specific CD4 Tconv (CD4 Tconv/Treg ratio, range 8-29) using a leukapheresis. We could not detect alloreactive T cells in this culture, besides TGFb-producing Tregs. The end-of-culture Tregs produced allospecific suppression with an IC50 between 1:1,000 and 1:10,000. We demonstrated for the first time that it is possible to detect and expand mHA specific Tregs from HLA-matched sibling pairs. Immunotherapy with mHA-specific Tregs against ubiquitous mHAs may prevent GVHD.

Ex Vivo Expansion of Human Tregs Specific for Alloantigens Presented Directly or Indirectly.

Regulatory T Cell Therapy for the Induction of Clinical Organ Transplantation Tolerance

Antigen-Dependent Suppression of Alloresponses by Foxp3-Induced Regulatory T Cells in Transplantation

Direct Expansion of Human Allospecific Foxp3(+)Cd4(+) Regulatory T Cells with Allogeneic B Cells for Therapeutic Application

Efficient and Selective Prevention of GVHD by Antigen-Specific Induced Tregs Via Linked-Suppression in Mice.

Efficient And Selective Prevention Of Graft-Versus-Host Disease By Ag-Specific Induced Regulatory T Cells In Mice

Human Regulatory T Cells Against Minor Histocompatibility Antigens: Ex Vivo Expansion for Prevention of Graft-Versus-host Disease.

Ex Vivo Expanded Human Non-Cytotoxic CD8+CD45RClow/− Tregs Efficiently Delay Skin Graft Rejection and GVHD in Humanized Mice

Transfer of Regulatory T Cells Generated Ex Vivo Modifies Graft Rejection Through Induction of Tolerogenic CD4+CD25+ Cells in the Recipient

CD8+Tregs Promote GVHD Prevention and Overcome the Impaired GVL Effect Mediated by CD4+Tregs in Mice

Conferring alloantigen specificity to regulatory T cells: A comparative analysis of cell preparations undergoing clinical development in transplantation

Prevention Of Graft-Versus-Host Disease By Hy-Specific Induced Tregs Through Activation-Dependent Manner

Efficient Induction and Expansion of Human Alloantigen-Specific CD8 Regulatory T Cells from Naive Precursors by CD40-Activated B Cells1

T regulatory cells as an immunotherapy for transplantation.

Efficient Induction and Expansion of Human Alloantigen-Specific Cd8 Regulatory T Cells from Naive Precursors by Cd40-Activated B Cells

Large-scale in vitro expansion of human regulatory T cells with potent xenoantigen-specific suppression

Human OX40L-CAR-Tregs target activated antigen-presenting cells and control T cell alloreactivity

Reduction of Foxp3+T Cell Subsets Involved in Incidence of Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Human HLA-DR+CD27+ Regulatory T Cells Show Enhanced Antigen-Specific Suppressive Function.

Regulatory T CELLS Specific for Minor Histocompatibility Antigens

Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation tolerance